Si mostrano 100 riferimenti a partire da 1 |
Per ulteriori informazioni selezionare i riferimenti di interesse.
Endovascular stent-grafting in the treatment of superficial femoral arteryocclusive disease
JOURNAL OF ENDOVASCULAR THERAPY
Excimer laser-assisted recanalization of long, chronic superficial femoralartery occlusions
JOURNAL OF ENDOVASCULAR THERAPY
New aspects of pharmacological reperfusion: from macro- to microlysis
EUROPEAN HEART JOURNAL SUPPLEMENTS
Keeping the coronary arteries open: current opportunities
HOSPITAL MEDICINE
Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model
BLOOD COAGULATION & FIBRINOLYSIS
Adaptive remodeling of the infarct-related artery is associated with recurrent ischemic events after thrombolysis in acute myocardial infarction
CORONARY ARTERY DISEASE
Ticlopidine versus aspirin after myocardial infarction (STAMI) trial
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial
STROKE
Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: Synthesis and pharmacological evaluation of 2-oxopiperazine derivatives
JOURNAL OF MEDICINAL CHEMISTRY
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies
CIRCULATION
Antiplatelet therapy
HOSPITAL MEDICINE
Antithrombotic agents after peripheral transluminal angioplasty: a review of the studies, methods and evidence for their use
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
Moderate alcohol consumption is associated with decreased platelet activity in patients presenting with acute myocardial infarction
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Argatroban and alteplase in patients with acute myocardial infarction: TheARGAMI study
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Failed thrombolysis in myocardial infarction
INTERNATIONAL JOURNAL OF CARDIOLOGY
Severity of residual stenosis of infarct-related lesion and left ventricular function after single-vessel anterior wall myocardial infarction: Implication of ST-segment elevation in lead aVL of the admission electrocardiograms
CLINICAL CARDIOLOGY
Enhanced shear-induced von Willebrand factor binding to platelets in acutemyocardial infarction
THROMBOSIS RESEARCH
Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor
THROMBOSIS RESEARCH
Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine - Continuous platelet inhibition by the combination of abciximab and ticlopidine
CIRCULATION
Endogenous tissue factor pathway inhibitor modulates thrombus formation inan in vivo model of rabbit carotid artery stenosis and endothelial injury
CIRCULATION
Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor
CIRCULATION
Collaborative Angiographic Patency Trial of Recombinant Staphylokinase (CAPTORS)
AMERICAN HEART JOURNAL
Antiplatelet drugs in the acute phase of myocardial infarction
EUROPEAN HEART JOURNAL SUPPLEMENTS
Prediction of infarct-related coronary artery patency after thrombolytic therapy in acute myocardial infarction: Use of ST-segment as a non-invasive marker
Journal of cardiovascular diagnosis and procedures
Treatment of unstable angina: The role of platelet inhibitors and anticoagulants
JOURNAL OF INVASIVE CARDIOLOGY
Improving reperfusion after myocardial infarction - Using glycoprotein IIb/IIIb antagonists as adjuncts to fibrinolytic therapy holds promise
BRITISH MEDICAL JOURNAL
Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction
CORONARY ARTERY DISEASE
Have we reached the limit with thrombolytic therapy?
CARDIOVASCULAR DRUGS AND THERAPY
Overcoming thrombolytic resistance - Rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction - Results of the HIT-4 trial
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Editorial comment. Infarct-related artery after thrombolysis: to see or not to see?
REVISTA ESPANOLA DE CARDIOLOGIA
Acute coronary syndromes, role of angioplasty in the stent-era
REVISTA ESPANOLA DE CARDIOLOGIA
Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy
INTERNATIONAL JOURNAL OF CARDIOLOGY
Long-term arterial patency after coronary reperfusion
INTERNATIONAL JOURNAL OF CARDIOLOGY
Association of plasma levels of activated protein C with recanalization ofthe infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction
THROMBOSIS RESEARCH
Percutaneous transluminal coronary angioplasty, alone or in combination with urokinase therapy, during acute myocardial infarction
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
Coronary angioplasty with or without stent implantation for acute myocardial infarction
NEW ENGLAND JOURNAL OF MEDICINE
A primary stenting strategy as an alternative to fibrinolytic therapy in acute myocardial infarction - An analysis of results in hospital and at 6 weeks and 6 months
MEDICAL JOURNAL OF AUSTRALIA
Potent bivalent thrombin inhibitors: Replacement of the scissile peptide bond at P-1-P-1 ' with arginyl ketomethylene isosteres
JOURNAL OF MEDICINAL CHEMISTRY
Abciximab facilitates the rate and extent of thrombolysis - Results of thethrombolysis in myocardial infarction (TIMI) 14 trial
CIRCULATION
Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial)
AMERICAN JOURNAL OF CARDIOLOGY
CORONARY THROMBOSIS THROMBOLYSIS IN PIGS - EFFECTS OF HEPARIN, ASA, AND THE THROMBIN INHIBITOR INOGATRAN/
Journal of pharmacological and toxicological methods
COMPARATIVE TIME-COURSE OF THROMBOLYSIS INDUCED BY INTRAVENOUS BOLUSES AND INFUSION OF STAPHYLOKINASE AND TISSUE-PLASMINOGEN ACTIVATOR IN ARABBIT ARTERIAL THROMBOSIS MODEL
Blood coagulation & fibrinolysis
BOLUS ADMINISTRATION OF SARUPLASE IN EUROPE (BASE), A PILOT-STUDY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
Journal of thrombosis and thrombolysis
A RANDOMIZED, BLINDED STUDY OF 2 DOSES OF NOVASTAN(R) (BRAND OF ARGATROBAN) VERSUS HEPARIN AS ADJUNCTIVE THERAPY TO RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (ACCELERATED ADMINISTRATION) IN ACUTE MYOCARDIAL-INFARCTION - RATIONALE AND DESIGN OF THE MYOCARDIAL-INFARCTION USING NOVASTAN(R) AND T-PA (MINT) STUDY
Journal of thrombosis and thrombolysis
PLATELET ACTIVITY IN THE EARLY-STAGE OF ACUTE MYOCARDIAL-INFARCTION -RELATION TO TIME OF PRESENTATION, TREATMENT WITH EITHER TISSUE-PLASMINOGEN ACTIVATOR OR STREPTOKINASE AND CYCLOOXYGENASE INHIBITION
Journal of thrombosis and thrombolysis
AN OPEN DESIGN, MULTICENTER, RANDOMIZED TRIAL OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY VERSUS STENTING, WITH A HEPARIN-COATED STENT, OF TOTALLY OCCLUDED CORONARY-ARTERIES - RATIONALE, TRIAL DESIGN ANDBASE-LINE PATIENT CHARACTERISTICS
Canadian journal of cardiology
EFFECTS OF RETEPLASE AND ALTEPLASE ON PLATELET-AGGREGATION AND MAJOR RECEPTOR EXPRESSION DURING THE FIRST 24 HOURS OF ACUTE MYOCARDIAL-INFARCTION TREATMENT
Journal of the American College of Cardiology
PROTEOLYSIS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) BY PLASMIN - EFFECT ON TFPI ACTIVITY
Thrombosis and haemostasis
EFFECTIVE USE OF BCH-2763, A NEW POTENT INJECTABLE DIRECT THROMBIN INHIBITOR, IN COMBINATION WITH TISSUE-PLASMINOGEN ACTIVATOR (TPA) IN A RAT ARTERIAL THROMBOLYSIS MODEL
Thrombosis and haemostasis
EFFECT OF A SYNTHETIC FACTOR XA INHIBITOR, YM-60828, ON BLOOD-VESSEL PATENCY IN COMBINATION WITH A THROMBOLYTIC AGENT AND ON BLOOD-LOSS FROM THE OPERATION SITE IN A RAT MODEL OF ARTERIAL THROMBOSIS
Thrombosis and haemostasis
The beneficial effect of a beta-D-xyloside, iliparcil, in the prevention of postthrombolytic rethrombosis in the rat
HAEMOSTASIS
LOW-MOLECULAR-WEIGHT HEPARIN (REVIPARIN) REDUCES THE INCIDENCE OF FEMOROPOPLITEAL IN-STENT STENOSIS - PRELIMINARY-RESULTS OF AN ONGOING STUDY
Cardiovascular and interventional radiology
FAILED CORONARY THROMBOLYSIS
Lancet
THE ANTITHROMBOTIC EFFECT OF POTENT BIFUNCTIONAL THROMBIN INHIBITORS BASED ON HIRUDIN SEQUENCE, P551 AND P532, ON HE-NE LASER-INDUCED THROMBOSIS IN RAT MESENTERIC MICROVESSELS
Thrombosis research
COMPARISON OF THROMBOLYTIC THERAPIES WITH MUTANT TPA (LANOTEPLASE SUN9216) AND RECOMBINANT TPA (ALTEPLASE) FOR ACUTE MYOCARDIAL-INFARCTION/
Japanese Circulation Journal
FUNCTIONAL RELEVANCE OF THE EXPRESSION OF LIGAND-INDUCED BINDING-SITES IN THE RESPONSE TO PLATELET GP LLB LLLA ANTAGONISTS IN-VIVO/
The Journal of pharmacology and experimental therapeutics
THROMBIN-INDUCED MITOGENESIS IN CORONARY-ARTERY SMOOTH-MUSCLE CELLS IS POTENTIATED BY THROMBOXANE A(2) AND INVOLVES UP-REGULATION OF THROMBOXANE RECEPTOR MESSENGER-RNA
Circulation
PATHOPHYSIOLOGICAL INSIGHT INTO THE POSSIBLE OPTIMAL THERAPIES FOR ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA
Circulation
CORONARY ANGIOSCOPIC FINDINGS IN THE INFARCT-RELATED VESSEL WITHIN 1 MONTH OF ACUTE MYOCARDIAL-INFARCTION - NATURAL-HISTORY AND THE EFFECT OF THROMBOLYSIS
Circulation
Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty
CIRCULATION
ANTITHROMBOTIC ACTIVITY OF A MONOCLONAL-ANTIBODY INDUCING THE SUBSTRATE FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN RAT MODELS OF VENOUS AND ARTERIAL THROMBOSIS
British Journal of Pharmacology
ABNORMAL CORONARY FLOW IN INFARCT ARTERIES 1 YEAR AFTER MYOCARDIAL-INFARCTION IS PREDICTED AT 4 WEEKS BY CORRECTED THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) FRAME COUNT AND STENOSIS SEVERITY
The American journal of cardiology
BENEFIT OF EARLY SUSTAINED REPERFUSION IN PATIENTS WITH PRIOR MYOCARDIAL-INFARCTION (THE GUSTO-I TRIAL)
The American journal of cardiology
TIMI FLOW AND SURROGATE END-POINTS - WHAT YOU SEE IS NOT ALWAYS WHAT YOU GET
The American heart journal
INCIDENCE AND PREDICTORS OF RESTENOSIS AFTER SUCCESSFUL PRIMARY CORONARY ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION - THE IMPORTANCE OF AGE AND PROCEDURAL RESULT
The American heart journal
HUMAN PLATELET ACTIVATION BY THROMBOLYTIC AGENTS - EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND UROKINASE ON PLATELET SURFACE P-SELECTIN EXPRESSION
The American heart journal
MELAGATRAN, AND HIRUDIN AND HEPARIN AS ADJUNCTS TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A CANINE MODEL OF CORONARY-ARTERY THROMBOLYSIS
Fibrinolysis & proteolysis
HEPARIN AFTER ACUTE MYOCARDIAL-INFARCTION
Cardiovascular drugs and therapy
PROGRESSION OF THE CULPRIT LESION IN UNSTABLE CORONARY-ARTERY DISEASEWITH WARFARIN AND ASPIRIN VERSUS ASPIRIN ALONE - PRELIMINARY-STUDY
Journal of the American College of Cardiology
RANDOMIZED COMPARISON OF PRIMARY CORONARY ANGIOPLASTY WITH THROMBOLYTIC THERAPY IN LOW-RISK PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
Journal of the American College of Cardiology
COMPARISON OF ENOXAPARIN, HIRULOG, AND HEPARIN AS ADJUNCTIVE ANTITHROMBOTIC THERAPY DURING THROMBOLYSIS WITH RTPA IN THE STENOSED CANINE CORONARY-ARTERY
Thrombosis and haemostasis
LATE REOPENING OF A PATENT DUCTUS-ARTERIO SUS AFTER COMPLETE CLOSURE WITH THE RASHKINDS PROSTHESIS - SUSPECT OF A TRAUMATIC ORIGIN
Revista espanola de cardiologia
NANOPARTICLE DRUG-DELIVERY SYSTEM FOR RESTENOSIS
Advanced drug delivery reviews
DYNAMICS OF CORONARY THROMBOLYSIS AND REOCCLUSION
Clinical cardiology
CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY
Journal of cardiovascular pharmacology
CHIMERIC FIBROLASE - COVALENT ATTACHMENT OF AN RGD-LIKE PEPTIDE TO CREATE A POTENTIALLY MORE EFFECTIVE THROMBOLYTIC AGENT
Thrombosis research
VASOMODULATORY ACTION OF CLOPIDOGREL AND TICLOPIDINE
Thrombosis research
THE ANTITHROMBOTIC EFFECT OF SYNTHETIC LOW-MOLECULAR-WEIGHT HUMAN FACTOR XA INHIBITOR DX-9065A, ON HE-NE LASER-INDUCED THROMBOSIS IN RAT MESENTERIC MICROVESSELS
Thrombosis research
TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/
Stroke
PREVENTION OF CAROTID-ARTERY THROMBOSIS BY ORAL PLATELET GPIIB IIIA ANTAGONIST IN DOGS/
Stroke
INTERACTION OF A THROMBIN INHIBITOR AND A PLATELET GP IIB IIIA ANTAGONIST IN-VIVO - EVIDENCE THAT THROMBIN MEDIATES PLATELET-AGGREGATION AND SUBSEQUENT THROMBOXANE A(2) FORMATION DURING CORONARY THROMBOLYSIS/
The Journal of pharmacology and experimental therapeutics
CHANGES IN R-WAVE AMPLITUDE - ECG-DIFFERENTIATION BETWEEN EPISODES OFREOCCLUSION AND REPERFUSION ASSOCIATED WITH ST-SEGMENT ELEVATION
Journal of electrocardiology
NOVEL LOW-MOLECULAR-WEIGHT INHIBITOR OF PAI-1 (XR5118) PROMOTES ENDOGENOUS FIBRINOLYSIS AND REDUCES POSTTHROMBOLYSIS THROMBUS GROWTH IN RABBITS
Circulation
ANTITHROMBOTIC POTENCY OF HIRUDIN IS INCREASED IN NONHUMAN-PRIMATES BY FIBRIN TARGETING
Circulation
COMBINED ACCELERATED TISSUE-PLASMINOGEN ACTIVATOR AND PLATELET GLYCOPROTEIN IIB IIIA INTEGRIN RECEPTOR BLOCKADE WITH INTEGRIN IN ACUTE MYOCARDIAL-INFARCTION - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL/
Circulation
PATENCY AND REINFARCTION IN LATE-ENTRY MYOCARDIAL INFARCT PATIENTS TREATED WITH REPERFUSION THERAPY
Angiology
EFFECTS OF THROMBOLYTIC REGIMEN, EARLY CATHETERIZATION, AND PREDISCHARGE ANGIOGRAPHIC VARIABLES ON 6-WEEK LEFT-VENTRICULAR FUNCTION
The American journal of cardiology
COMPARISON OF STANDARD AND DERIVED 12-LEAD ELECTROCARDIOGRAMS FOR DIAGNOSIS OF CORONARY ANGIOPLASTY-INDUCED MYOCARDIAL-ISCHEMIA
The American journal of cardiology
DIRECTIONAL CORONARY ATHERECTOMY FOR THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
The American heart journal
SIGNIFICANCE OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION SCORING SYSTEM IN ASSESSING INFARCT-RELATED ARTERY REPERFUSION AND MORTALITY-RATES AFTER ACUTE MYOCARDIAL-INFARCTION
The American heart journal
TREATMENT OF MYOCARDIAL-INFARCTION BY PTCA WITHIN 12 TO 24 HOURS AFTER ONSET OF PAIN
Deutsche Medizinische Wochenschrift
SERIAL CHANGES OF NATURAL ANTITHROMBOTICS DURING MYOCARDIAL ISCHEMIA-REPERFUSION IN SWINE - EFFECTS OF MAGNESIUM, DILTIAZEM, AND A NOVEL MAC-1 INHIBITOR
Blood coagulation & fibrinolysis
ADP-INDUCED P-SELECTIN EXPRESSION ON PLATELETS AS A PREDICTOR OF SUCCESSFUL THROMBOLYSIS
Blood coagulation & fibrinolysis
SELECTIVE-INHIBITION OF FACTOR XA DURING THROMBOLYTIC THERAPY MARKEDLY IMPROVES CORONARY-ARTERY PATENCY IN A CANINE MODEL OF CORONARY-THROMBOSIS
Blood coagulation & fibrinolysis
ANGIOGRAPHIC STUDIES DEMONSTRATING THE NEED FOR CONJUNCTIVE ANTICOAGULATION
Coronary artery disease
ARGATROBAN - A SYNTHETIC THROMBIN INHIBITOR OF LOW RELATIVE MOLECULAR-MASS
Coronary artery disease
ENHANCEMENT OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR THROMBOLYSIS WITH A SELECTIVE FACTOR XA INHIBITOR DERIVED FROM THE LEECH HIRUDO-MEDICINALIS - COMPARISON WITH HEPARIN AND HIRUDIN IN A RABBIT THROMBOSIS MODEL
Coronary artery disease